Bjourson, Tony Professor
Director - Biomedical Sciences Research Institute
Academic and Professional Qualifications
- 1996: PhD Molecular Signalling, Queen’s University of Belfast.
- 1992: MSc Biological Sciences, University of Ulster, Coleraine.
- 1982: HNC in Biomedical Sciences, Ulster Polytechnic College.
- 2007 - present: Director, Biomedical Sciences Research Institute
- 2005 - present: Professor of Genomics, University of Ulster, Coleraine.
- 2001 - 2005: Senior Lecturer in Genomics, University of Ulster, Coleraine.
- 1996 - 2001: Senior Scientific Officer, DARDNI/ QUB.
- 1990 - 1996: Senior Scientific Officer, DANI Science.
- 1986 - 1990: Higher Scientific Officer, DANI Science.
- 1982 - 1990: Scientific Officer, DANI Science.
- 1977 - 1982: Assistant Scientific Officer, DANI Science.
Biography Tony Bjourson was born in Strabane, Co Tyrone in Northern Ireland. He was appointed Director of the Biomedical Sciences Research Institute (BMSRI) at the University of Ulster in late 2007 and currently manages the 240 Researchers within the BMSRI. He obtained his MSc in Biological Sciences from the University of Ulster and his PhD from Queen’s University Belfast. He has over 28 years of research experience in a diverse range of molecular biological/genomic projects and he has published extensively in peer-reviewed molecular biology journals. Prior to joining Ulster in 2001, he established and managed genomic programmes for the DARDNI and Queens University Belfast and participated in the first ever international eukaryotic genome project (EU Yeast Genome sequencing program 1994-1996). In the early 1990’s he developed novel subtraction hybridisation technologies that were subsequently used for the identification of specific nucleic acid sequences in a diverse range of cell types. After joining Ulster he led the Pharmaceutical Biotechnology Research Group and subsequently established and led the Biomedical Genomics Research Group. He also managed the Core Genomics Unit within the Centre for Molecular Biosciences (CMB). He has considerable experience of managing both large research infrastructure projects, focused basic research projects, and overseeing delivery of associated objectives. Professor Bjourson currently serves as a Director on the boards of two companies; the Clinical Translation Research & Innovation Centre (C-TRIC) based in L/Derry aimed at translating biomedical research outputs from laboratory bench to patient bedside. He also serves on the Board of Directors of the Ulster venture company Innovation Ulster Ltd. His current research is focused on genomics based personalised medicine in the area of cancer and autoimmune disease and pharmacogenomic. He also is a Steering Committee member of the Northern Ireland Biobank, a Council Member of the Irish Society for Clinical genetics. He is also highly committed to economic regeneration in Ireland and the North West region in particular; he was a founding member of the North West Science & Technology Partnership (NWSTP) and the Clinical Translational Research & innovation Centre (C-TRIC).
Teaching & Learning Activities
Subject Areas: Genomics/ Bioinformatics; GM Plants; recombinant protein production.
Research Interests: Current research includes:
The isolation of biomarkers for personalised medicine relating to degenerative diseases including breast cancer (invasion and metastasis associated biomarkers).
An in vitro model of the pathway leading to breast cancer invasion has been generated and the genomic, transcriptomic (microRNA/mRNA), methylation status & proteomic signatures associated with invasion are investigated using laboratory technologies integrated with a systems biology approach
Rheumatoid arthritis (responsiveness to anti TNF alpha. -DEL Cast Studentship in colaboration with Belfast City Hospital / Musgrave Park Hospital).
Other research involves determining the potential for lateral transfer of genetic information from maternal breast milk to the neonate (Invest NI-Centre for Functional Genomics funded project).
Collaborative research on the genomics & proteomics of snake and amphibian venomics is also undertaken aimed at the isolation of new clinically relevant pharmaceutical drugs.
Bjourson, Tony Professor/table>